Cicor Technologies Ltd / Key word(s): Strategic Company Decision Ad hoc announcement pursuant to Art. 53 LR Bronschhofen, October 18, 2024 – Cicor Group (SIX Swiss Exchange: CICN) has decided to discontinue thin-film production at the Ulm site in Germany by the end of June 2025 and to concentrate production at the existing site in Wangs, Switzerland. Reinhardt Microtech AG, founded in 1984 and based in Wangs, acquired the thin-film technology business in Ulm in 1998 and has been operating it as Reinhardt Microtech GmbH since then. The company has been part of the Cicor Group since 2007 and is part of the Advanced Substrates Division. Contact
The Cicor Group is a globally active provider of full-cycle electronic solutions from research and development to manufacturing and supply chain management. Cicor’s approximately 3,300 employees at 19 locations are serving leaders from the medical, industrial and aerospace & defence industries. Cicor creates value to its customers through the combination of customer-specific development solutions, high-tech components, as well as electronic device manufacturing. The shares of Cicor Technologies Ltd. are traded at the SIX Swiss Exchange (CICN). For further information, please visit the website www.cicor.com. End of Inside Information |
Language: | English |
Company: | Cicor Technologies Ltd |
c/o Cicor Management AG, Gebenloostraße 15 | |
9552 Bronschhofen | |
Switzerland | |
Phone: | +41719137300 |
Fax: | +41719137301 |
E-mail: | info@cicor.com |
Internet: | www.cicor.com |
ISIN: | CH0008702190 |
Valor: | 870219 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 2010847 |
End of Announcement | EQS News Service |
|
2010847 18-Oct-2024 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.